Personalized Medicine Bioinformatics Global Market Report 2025
Description
Personalized Medicine Bioinformatics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on personalized medicine bioinformatics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for personalized medicine bioinformatics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The personalized medicine bioinformatics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Technology: Gene Sequencing; Pharmacogenomics; Microarray Technology; Artificial Intelligence-Driven Analytics Platforms; Other Technologies
2) By Application: Genomics; Proteomics; Transcriptomics; Metabolomics; Epigenomics; Other Applications
3) By End-User: Biotechnology And Pharmaceutical Companies; Clinical Diagnostics Laboratories; Hospitals And Academic Medical Centers; Contact Research Organizations and Biobanks; Other End-Users
Subsegments:
1) By Gene Sequencing: Next-Generation Sequencing (NGS); Sanger Sequencing; Single-Molecule Real-Time Sequencing (SMRT); Whole Exome Sequencing (WES); Whole Genome Sequencing (WGS)
2) By Pharmacogenomics: Drug-Gene Interaction Analysis; Adverse Drug Reaction (ADR) Prediction; Biomarker Discovery; Personalized Drug Response Profiling
3) By Microarray Technology: DNA Microarray; RNA Microarray; Protein Microarray; Comparative Genomic Hybridization (CGH) Microarray
4) By Artificial Intelligence-Driven Analytics Platforms: Machine Learning-Based Platforms; Deep Learning-Based Platforms; Natural Language Processing (NLP) Platforms; Predictive Analytics Platforms; Clinical Decision Support Systems (CDSS)
5) By Other Technologies: Proteomics Analysis; Metabolomics Analysis; Epigenomics Profiling; Bioinformatics Cloud Platforms
Companies Mentioned: F. Hoffmann-La Roche AG; Merck KGaA Darmstadt Germany; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Myriad Genetics Inc.; Guardant Health Inc.; Sophia Genetics SA; DNAnexus Inc.; Deep Genomics Inc.; Congenica Ltd; Phase Genomics Inc.; Analome Inc.; Pluto Bioinformatics Inc.; BioBam Bioinformatics S.L.; OncoBox Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on personalized medicine bioinformatics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for personalized medicine bioinformatics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The personalized medicine bioinformatics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Technology: Gene Sequencing; Pharmacogenomics; Microarray Technology; Artificial Intelligence-Driven Analytics Platforms; Other Technologies
2) By Application: Genomics; Proteomics; Transcriptomics; Metabolomics; Epigenomics; Other Applications
3) By End-User: Biotechnology And Pharmaceutical Companies; Clinical Diagnostics Laboratories; Hospitals And Academic Medical Centers; Contact Research Organizations and Biobanks; Other End-Users
Subsegments:
1) By Gene Sequencing: Next-Generation Sequencing (NGS); Sanger Sequencing; Single-Molecule Real-Time Sequencing (SMRT); Whole Exome Sequencing (WES); Whole Genome Sequencing (WGS)
2) By Pharmacogenomics: Drug-Gene Interaction Analysis; Adverse Drug Reaction (ADR) Prediction; Biomarker Discovery; Personalized Drug Response Profiling
3) By Microarray Technology: DNA Microarray; RNA Microarray; Protein Microarray; Comparative Genomic Hybridization (CGH) Microarray
4) By Artificial Intelligence-Driven Analytics Platforms: Machine Learning-Based Platforms; Deep Learning-Based Platforms; Natural Language Processing (NLP) Platforms; Predictive Analytics Platforms; Clinical Decision Support Systems (CDSS)
5) By Other Technologies: Proteomics Analysis; Metabolomics Analysis; Epigenomics Profiling; Bioinformatics Cloud Platforms
Companies Mentioned: F. Hoffmann-La Roche AG; Merck KGaA Darmstadt Germany; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Myriad Genetics Inc.; Guardant Health Inc.; Sophia Genetics SA; DNAnexus Inc.; Deep Genomics Inc.; Congenica Ltd; Phase Genomics Inc.; Analome Inc.; Pluto Bioinformatics Inc.; BioBam Bioinformatics S.L.; OncoBox Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Personalized Medicine Bioinformatics Market Characteristics
- 3. Personalized Medicine Bioinformatics Market Trends And Strategies
- 4. Personalized Medicine Bioinformatics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
- 5. Global Personalized Medicine Bioinformatics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Personalized Medicine Bioinformatics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Personalized Medicine Bioinformatics Market Growth Rate Analysis
- 5.4. Global Personalized Medicine Bioinformatics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Personalized Medicine Bioinformatics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Personalized Medicine Bioinformatics Total Addressable Market (TAM)
- 6. Personalized Medicine Bioinformatics Market Segmentation
- 6.1. Global Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Gene Sequencing
- Pharmacogenomics
- Microarray Technology
- Artificial Intelligence-Driven Analytics Platforms
- Other Technologies
- 6.2. Global Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Genomics
- Proteomics
- Transcriptomics
- Metabolomics
- Epigenomics
- Other Applications
- 6.3. Global Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biotechnology And Pharmaceutical Companies
- Clinical Diagnostics Laboratories
- Hospitals And Academic Medical Centres
- Contact Research Organization and Biobanks
- Other End-Users
- 6.4. Global Personalized Medicine Bioinformatics Market, Sub-Segmentation Of Gene Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Next-Generation Sequencing (NGS)
- Sanger Sequencing
- Single-Molecule Real-Time Sequencing (SMRT)
- Whole Exome Sequencing (WES)
- Whole Genome Sequencing (WGS)
- 6.5. Global Personalized Medicine Bioinformatics Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug-Gene Interaction Analysis
- Adverse Drug Reaction (ADR) Prediction
- Biomarker Discovery
- Personalized Drug Response Profiling
- 6.6. Global Personalized Medicine Bioinformatics Market, Sub-Segmentation Of Microarray Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Deoxyribonucleic Acid (DNA) Microarray
- Ribonucleic Acid (RNA) Microarray
- Protein Microarray
- Comparative Genomic Hybridization (CGH) Microarray
- 6.7. Global Personalized Medicine Bioinformatics Market, Sub-Segmentation Of Artificial Intelligence-Driven Analytics Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Machine Learning-Based Platforms
- Deep Learning-Based Platforms
- Natural Language Processing (NLP) Platforms
- Predictive Analytics Platforms
- Clinical Decision Support Systems (CDSS)
- 6.8. Global Personalized Medicine Bioinformatics Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Proteomics Analysis
- Metabolomics Analysis
- Epigenomics Profiling
- Bioinformatics Cloud Platforms
- 7. Personalized Medicine Bioinformatics Market Regional And Country Analysis
- 7.1. Global Personalized Medicine Bioinformatics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Personalized Medicine Bioinformatics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Personalized Medicine Bioinformatics Market
- 8.1. Asia-Pacific Personalized Medicine Bioinformatics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Personalized Medicine Bioinformatics Market
- 9.1. China Personalized Medicine Bioinformatics Market Overview
- 9.2. China Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Personalized Medicine Bioinformatics Market
- 10.1. India Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Personalized Medicine Bioinformatics Market
- 11.1. Japan Personalized Medicine Bioinformatics Market Overview
- 11.2. Japan Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Personalized Medicine Bioinformatics Market
- 12.1. Australia Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Personalized Medicine Bioinformatics Market
- 13.1. Indonesia Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Personalized Medicine Bioinformatics Market
- 14.1. South Korea Personalized Medicine Bioinformatics Market Overview
- 14.2. South Korea Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Personalized Medicine Bioinformatics Market
- 15.1. Western Europe Personalized Medicine Bioinformatics Market Overview
- 15.2. Western Europe Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Personalized Medicine Bioinformatics Market
- 16.1. UK Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Personalized Medicine Bioinformatics Market
- 17.1. Germany Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Personalized Medicine Bioinformatics Market
- 18.1. France Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Personalized Medicine Bioinformatics Market
- 19.1. Italy Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Personalized Medicine Bioinformatics Market
- 20.1. Spain Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Personalized Medicine Bioinformatics Market
- 21.1. Eastern Europe Personalized Medicine Bioinformatics Market Overview
- 21.2. Eastern Europe Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Personalized Medicine Bioinformatics Market
- 22.1. Russia Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Personalized Medicine Bioinformatics Market
- 23.1. North America Personalized Medicine Bioinformatics Market Overview
- 23.2. North America Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Personalized Medicine Bioinformatics Market
- 24.1. USA Personalized Medicine Bioinformatics Market Overview
- 24.2. USA Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Personalized Medicine Bioinformatics Market
- 25.1. Canada Personalized Medicine Bioinformatics Market Overview
- 25.2. Canada Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Personalized Medicine Bioinformatics Market
- 26.1. South America Personalized Medicine Bioinformatics Market Overview
- 26.2. South America Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Personalized Medicine Bioinformatics Market
- 27.1. Brazil Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Personalized Medicine Bioinformatics Market
- 28.1. Middle East Personalized Medicine Bioinformatics Market Overview
- 28.2. Middle East Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Personalized Medicine Bioinformatics Market
- 29.1. Africa Personalized Medicine Bioinformatics Market Overview
- 29.2. Africa Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Personalized Medicine Bioinformatics Market Competitive Landscape And Company Profiles
- 30.1. Personalized Medicine Bioinformatics Market Competitive Landscape
- 30.2. Personalized Medicine Bioinformatics Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck KGaA Darmstadt Germany Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 31. Personalized Medicine Bioinformatics Market Other Major And Innovative Companies
- 31.1. Laboratory Corporation of America Holdings
- 31.2. Quest Diagnostics Incorporated
- 31.3. Agilent Technologies Inc.
- 31.4. Illumina Inc.
- 31.5. Bio-Rad Laboratories Inc.
- 31.6. QIAGEN N.V.
- 31.7. Myriad Genetics Inc.
- 31.8. Guardant Health Inc.
- 31.9. Sophia Genetics SA
- 31.10. DNAnexus Inc.
- 31.11. Deep Genomics Inc.
- 31.12. Congenica Ltd
- 31.13. Phase Genomics Inc.
- 31.14. Analome Inc.
- 31.15. Pluto Bioinformatics Inc.
- 32. Global Personalized Medicine Bioinformatics Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Personalized Medicine Bioinformatics Market
- 34. Recent Developments In The Personalized Medicine Bioinformatics Market
- 35. Personalized Medicine Bioinformatics Market High Potential Countries, Segments and Strategies
- 35.1 Personalized Medicine Bioinformatics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Personalized Medicine Bioinformatics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Personalized Medicine Bioinformatics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


